Also is there any upper age limit where alendronate would no longer be considered as an appropriate treatment.
Bone loss accelerates with advancing age.
Effects occur most rapidly over the first 6 to 12 months of therapy. BMD continues to increase with continued drug administration. Currently there is a leaning towards HRT in younger and bisphosphonates in older persons. Care should be taken with the elderly with decreased renal function as alendronate should not be prescribed to patients with a creatinine clearance Reply to sender. . . . . . . . . . . . . . Post reply to RxConsult.